Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03853733 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 1, 2023 to Mar 1, 2027
    • Study completion date: Mar 1, 2025 to Mar 1, 2027
    v9
  2. Trial status: Completed to Recruiting
    • Study completion date: Mar 1, 2023 to Mar 1, 2025
    • Site details revised
    v8
  3. Trial status: Active, Not Recruiting to Completedv7
  4. Study title shortened, about 4 wordsv6
  5. Primary and study completion dates: Mar 1, 2022 to Mar 1, 2023
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. 2 versions Re-verified since Jul 15, 2020, no change to tracked fieldsv3-v4
  2. Study description revisedv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Many patients with rectal cancer were not candidates for surgical resection because advanced age, comorbidities, or multiple synchronous metastases. In this scenario only comfort measures or different palliative radiotherapy regimens are applied, from single doses to treatments lasting several weeks. The aim of this prospective study is to describe the preliminary results of our protocol of hypofractionated palliative radiotherapy in patients with non-operable rectal cancer.
Trial Details
NCT Number NCT03853733
Lead Sponsor Consorci Sanitari de Terrassa
Conditions
(from sponsor)		 Rectal Cancer
Related terms Gastrointestinal Hemorrhage, Rectal Neoplasms
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov